These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 15813818

  • 1. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.
    Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J, Hijnen DJ, Plötz S, Knol EF, Kapp A, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS.
    Allergy; 2005 May; 60(5):693-6. PubMed ID: 15813818
    [Abstract] [Full Text] [Related]

  • 2. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 3. No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.
    Oldhoff JM, Darsow U, Werfel T, Bihari IC, Katzer K, Laifaoui J, Plötz S, Kapp A, Knol EF, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS.
    Int Arch Allergy Immunol; 2006 Mar; 141(3):290-4. PubMed ID: 16931891
    [Abstract] [Full Text] [Related]

  • 4. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 5. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC, International Mepolizumab Study Group.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1062-71. PubMed ID: 17872493
    [Abstract] [Full Text] [Related]

  • 6. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
    Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A.
    Allergy; 2005 May 01; 60(5):685-8. PubMed ID: 15813816
    [Abstract] [Full Text] [Related]

  • 7. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
    Angelova-Fischer I, Hipler UC, Bauer A, Fluhr JW, Tsankov N, Fischer TW, Elsner P.
    Br J Dermatol; 2006 Jun 01; 154(6):1112-7. PubMed ID: 16704642
    [Abstract] [Full Text] [Related]

  • 8. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML, Di Lorenzo G, Martinelli N, Mansueto P, Rini GB, Corrocher R.
    Clin Exp Allergy; 2004 Apr 01; 34(4):639-45. PubMed ID: 15080819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC.
    Int J Dermatol; 2007 Dec 01; 46(12):1258-62. PubMed ID: 18173519
    [Abstract] [Full Text] [Related]

  • 11. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
    Hon KL, Lam MC, Leung TF, Kam WY, Lee KC, Li MC, Fok TF, Ng PC.
    Br J Dermatol; 2006 Apr 01; 154(4):629-35. PubMed ID: 16536804
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
    Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E.
    J Allergy Clin Immunol; 2004 Feb 01; 113(2):334-40. PubMed ID: 14767451
    [Abstract] [Full Text] [Related]

  • 15. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA, Tomoum HY, Salem SA, Abd El-Aziz MM, Abou El-Maged DI, El-Sayed El-Far I.
    Pediatr Allergy Immunol; 2008 Dec 01; 19(8):756-62. PubMed ID: 18435706
    [Abstract] [Full Text] [Related]

  • 16. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP.
    Br J Dermatol; 2009 Aug 01; 161(2):427-34. PubMed ID: 19416227
    [Abstract] [Full Text] [Related]

  • 17. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
    Fujisawa T, Nagao M, Hiraguchi Y, Katsumata H, Nishimori H, Iguchi K, Kato Y, Higashiura M, Ogawauchi I, Tamaki K.
    Pediatr Allergy Immunol; 2009 Nov 01; 20(7):633-41. PubMed ID: 19236603
    [Abstract] [Full Text] [Related]

  • 18. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
    Hon KL, Lam MC, Wong KY, Leung TF, Ng PC.
    Br J Dermatol; 2007 Nov 01; 157(5):922-5. PubMed ID: 17725670
    [Abstract] [Full Text] [Related]

  • 19. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
    Song TW, Sohn MH, Kim ES, Kim KW, Kim KE.
    Clin Exp Allergy; 2006 Mar 01; 36(3):346-51. PubMed ID: 16499646
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
    Hon KL, Leung TF, Ma KC, Li AM, Wong Y, Fok TF.
    Clin Exp Dermatol; 2004 May 01; 29(3):293-6. PubMed ID: 15115514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.